Back to Search Start Over

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

Authors :
Noda, Kazumasa
Nishiwaki, Yutaka
Kawahara, Masaaki
Negoro, Shunichi
Sugiura, Takahiko
Yokoyama, Akira
Fukuoka, Masahiro
Mori, Kiyoshi
Watanabe, Koshiro
Tamura, Tomohide
Yamamoto, Seiichiro
Saijo, Nagahiro
Source :
The New England Journal of Medicine. Jan 10, 2002, Vol. 346 Issue 2, p85, 7 p.
Publication Year :
2002

Abstract

The chemotherapy drugs irinotecan and cisplatin appear to be more effective than etoposide and cisplatin for treating small-cell lung cancer, according to a study of 154 patients. After two years, 19% of the patients who received irinotecan and cisplatin were still alive, compared to 5% of the patients who received etoposide and cisplatin.

Details

ISSN :
00284793
Volume :
346
Issue :
2
Database :
Gale General OneFile
Journal :
The New England Journal of Medicine
Publication Type :
Academic Journal
Accession number :
edsgcl.82032726